IRIS Accounts Production v23.4.0.336 13433227 Board of Directors 1.7.22 30.6.23 30.6.23 false true false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh134332272022-06-30134332272023-06-30134332272022-07-012023-06-30134332272021-06-01134332272021-06-022022-06-30134332272022-06-3013433227ns15:EnglandWales2022-07-012023-06-3013433227ns14:PoundSterling2022-07-012023-06-3013433227ns10:Director12022-07-012023-06-3013433227ns10:PrivateLimitedCompanyLtd2022-07-012023-06-3013433227ns10:SmallEntities2022-07-012023-06-3013433227ns10:AuditExempt-NoAccountantsReport2022-07-012023-06-3013433227ns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3013433227ns10:SmallCompaniesRegimeForAccounts2022-07-012023-06-3013433227ns10:AbridgedAccounts2022-07-012023-06-3013433227ns10:OrdinaryShareClass12022-07-012023-06-3013433227ns10:Director22022-07-012023-06-3013433227ns10:RegisteredOffice2022-07-012023-06-3013433227ns5:CurrentFinancialInstruments2023-06-3013433227ns5:CurrentFinancialInstruments2022-06-3013433227ns5:ShareCapital2023-06-3013433227ns5:ShareCapital2022-06-3013433227ns5:RetainedEarningsAccumulatedLosses2023-06-3013433227ns5:RetainedEarningsAccumulatedLosses2022-06-3013433227ns10:OrdinaryShareClass12023-06-30
REGISTERED NUMBER: 13433227 (England and Wales)















ABRIDGED UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2023

FOR

AROMACLINIC LTD

AROMACLINIC LTD (REGISTERED NUMBER: 13433227)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


AROMACLINIC LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2023







DIRECTORS: V Kothari
Mrs J Kothari





REGISTERED OFFICE: 37 Chestnut Drive
Harrow
United Kingdom
Middlesex
HA3 7DL





REGISTERED NUMBER: 13433227 (England and Wales)





ACCOUNTANTS: ST-Partnership
Chartered Accountants
Enterprise House
3 Tudor Enterprise Park
Tudor Road
Harrow
Middlesex
HA3 5JQ

AROMACLINIC LTD (REGISTERED NUMBER: 13433227)

ABRIDGED BALANCE SHEET
30 JUNE 2023

2023 2022
Notes £    £   
CURRENT ASSETS
Debtors 587 104
Cash at bank 1,558 1,036
2,145 1,140
CREDITORS
Amounts falling due within one year 7,027 4,869
NET CURRENT LIABILITIES (4,882 ) (3,729 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(4,882

)

(3,729

)

CAPITAL AND RESERVES
Called up share capital 4 100 100
Retained earnings (4,982 ) (3,829 )
SHAREHOLDERS' FUNDS (4,882 ) (3,729 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 30 June 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 February 2024 and were signed on its behalf by:





V Kothari - Director


AROMACLINIC LTD (REGISTERED NUMBER: 13433227)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023


1. STATUTORY INFORMATION

Aromaclinic Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on the going concern basis. At the balance sheet date the company has a net deficit of £4,882 (2022: £3,729). The Director is confident that the company will continue to operate within the extended credit terms currently offered by its creditors. On this basis the Director considers it appropriate to prepare these financial statements on the going concern basis. The financial statements do not include any adjustments that would result from a withdrawal of these extended credit terms.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary shares 1 100 100